BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23970038)

  • 1. Elucidation of the BACE1 regulating factor GGA3 in Alzheimer's disease.
    Natunen T; Parrado AR; Helisalmi S; Pursiheimo JP; Sarajärvi T; Mäkinen P; Kurkinen KM; Mullin K; Alafuzoff I; Haapasalo A; Bertram L; Soininen H; Tanzi RE; Hiltunen M
    J Alzheimers Dis; 2013; 37(1):217-32. PubMed ID: 23970038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of GGA3 protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein.
    Santosa C; Rasche S; Barakat A; Bellingham SA; Ho M; Tan J; Hill AF; Masters CL; McLean C; Evin G
    Neurobiol Dis; 2011 Jul; 43(1):176-83. PubMed ID: 21440067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice.
    Kim W; Ma L; Lomoio S; Willen R; Lombardo S; Dong J; Haydon PG; Tesco G
    Mol Neurodegener; 2018 Feb; 13(1):6. PubMed ID: 29391027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BACE1 mRNA expression in Alzheimer's disease postmortem brain tissue.
    Coulson DT; Beyer N; Quinn JG; Brockbank S; Hellemans J; Irvine GB; Ravid R; Johnston JA
    J Alzheimers Dis; 2010; 22(4):1111-22. PubMed ID: 20930286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Β-site APP-cleaving enzyme 1 trafficking and Alzheimer's disease pathogenesis.
    Tan J; Evin G
    J Neurochem; 2012 Mar; 120(6):869-80. PubMed ID: 22171895
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Lomoio S; Willen R; Kim W; Ho KZ; Robinson EK; Prokopenko D; Kennedy ME; Tanzi RE; Tesco G
    Sci Transl Med; 2020 Nov; 12(570):. PubMed ID: 33208500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Deletion of the Clathrin Adaptor GGA3 Reduces Anxiety and Alters GABAergic Transmission.
    Walker KR; Modgil A; Albrecht D; Lomoio S; Haydon PG; Moss SJ; Tesco G
    PLoS One; 2016; 11(5):e0155799. PubMed ID: 27192432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of seladin-1 increases BACE1 levels and activity through enhanced GGA3 depletion during apoptosis.
    Sarajärvi T; Haapasalo A; Viswanathan J; Mäkinen P; Laitinen M; Soininen H; Hiltunen M
    J Biol Chem; 2009 Dec; 284(49):34433-43. PubMed ID: 19815556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study between Alzheimer's disease and genes involved in Abeta biosynthesis, aggregation and degradation: suggestive results with BACE1.
    Clarimón J; Bertranpetit J; Calafell F; Boada M; Tàrraga L; Comas D
    J Neurol; 2003 Aug; 250(8):956-61. PubMed ID: 12928915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Endosome-associated Deubiquitinating Enzyme USP8 Regulates BACE1 Enzyme Ubiquitination and Degradation.
    Yeates EF; Tesco G
    J Biol Chem; 2016 Jul; 291(30):15753-66. PubMed ID: 27302062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity.
    Tesco G; Koh YH; Kang EL; Cameron AN; Das S; Sena-Esteves M; Hiltunen M; Yang SH; Zhong Z; Shen Y; Simpkins JW; Tanzi RE
    Neuron; 2007 Jun; 54(5):721-37. PubMed ID: 17553422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BACE1 activity in cerebrospinal fluid and its relation to markers of AD pathology.
    Mulder SD; van der Flier WM; Verheijen JH; Mulder C; Scheltens P; Blankenstein MA; Hack CE; Veerhuis R
    J Alzheimers Dis; 2010; 20(1):253-60. PubMed ID: 20164582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BACE1 in Alzheimer's disease.
    Sathya M; Premkumar P; Karthick C; Moorthi P; Jayachandran KS; Anusuyadevi M
    Clin Chim Acta; 2012 Dec; 414():171-8. PubMed ID: 22926063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain.
    Stockley JH; O'Neill C
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):574-6. PubMed ID: 17511655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin regulates GGA3-mediated degradation of BACE1.
    Kang EL; Cameron AN; Piazza F; Walker KR; Tesco G
    J Biol Chem; 2010 Jul; 285(31):24108-19. PubMed ID: 20484053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-3 cleavage of GGA3 stabilizes BACE: implications for Alzheimer's disease.
    Vassar R
    Neuron; 2007 Jun; 54(5):671-3. PubMed ID: 17553417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA aptamers selectively modulate protein recruitment to the cytoplasmic domain of beta-secretase BACE1 in vitro.
    Rentmeister A; Bill A; Wahle T; Walter J; Famulok M
    RNA; 2006 Sep; 12(9):1650-60. PubMed ID: 16888322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.
    Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ
    J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between the polymorphisms of beta-site APP-cleaving enzyme 2 (BACE2) 5'-flanking region and sporadic Alzheimer's disease.
    Yu Y; Jia J
    Brain Res; 2009 Feb; 1257():10-5. PubMed ID: 19124009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.